- Home
- PODC vs ONCY Comparison
PODC vs ONCY Comparison
Compare PODC & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODC
- ONCY
- Stock Information
- Founded
- PODC 2013
- ONCY 1998
- Country
- PODC United States
- ONCY Canada
- Employees
- PODC N/A
- ONCY N/A
- Industry
- PODC
- ONCY Pharmaceuticals and Biotechnology
- Sector
- PODC
- ONCY Health Care
- Exchange
- PODC Nasdaq
- ONCY Nasdaq
- Market Cap
- PODC 44.1M
- ONCY 49.2M
- IPO Year
- PODC N/A
- ONCY 1999
- Fundamental
- Price
- PODC $1.81
- ONCY $0.56
- Analyst Decision
- PODC Strong Buy
- ONCY Strong Buy
- Analyst Count
- PODC 1
- ONCY 3
- Target Price
- PODC $5.00
- ONCY $4.33
- AVG Volume (30 Days)
- PODC 36.1K
- ONCY 330.3K
- Earning Date
- PODC 05-29-2025
- ONCY 05-08-2025
- Dividend Yield
- PODC N/A
- ONCY N/A
- EPS Growth
- PODC N/A
- ONCY N/A
- EPS
- PODC N/A
- ONCY N/A
- Revenue
- PODC $49,729,000.00
- ONCY N/A
- Revenue This Year
- PODC $20.67
- ONCY N/A
- Revenue Next Year
- PODC $19.09
- ONCY N/A
- P/E Ratio
- PODC N/A
- ONCY N/A
- Revenue Growth
- PODC 22.98
- ONCY N/A
- 52 Week Low
- PODC $1.10
- ONCY $0.47
- 52 Week High
- PODC $2.85
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- PODC 51.94
- ONCY 45.75
- Support Level
- PODC $1.45
- ONCY $0.47
- Resistance Level
- PODC $1.99
- ONCY $0.65
- Average True Range (ATR)
- PODC 0.22
- ONCY 0.05
- MACD
- PODC 0.04
- ONCY 0.01
- Stochastic Oscillator
- PODC 59.72
- ONCY 50.00
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.